Thanks for the link, keeper. I had seen info on this patent, but I hadn't actually seen the patent listing in all its detail.
Some of you may remember this very topic was beaten to death on here back in 2007. At that time, healingwell member fc1001 said he had emailed the doctors involved, asking for published data. They never responded.
Quite frankly, one might think I'm impressed by the patent, but having been in the technology industry the past 13 years, the opposite is actually true. I know just how easy it can be to patent a bunch of, well, BS, in certain circumstances. You just need to make it sound good.
And I find it quite interesting that the two doctors so heavily involved in promoting buproprion and its anti-TNF efficacy are (1) the patent owners, and (2) paid consultants by Glaxo, maker of Wellbutrin. ubob claims that financial interests are keeping buproprion from being studied more, but I submit the opposite conspiracy theory: Drs. Kast and Altschuler, and Glaxo, have a rather large financial stake involved if buproprion does prove successful. So they're going to leak as much positive "preliminary" results as possible. The fact those preliminary results never became publishable, final results speaks volumes to me.
One final note: A couple of posters in the thread from 2007 said they could not tolerate the side effects of wellbutrin. This goes to show that its "safety" isn't quite as good as claimed. Like I've said, all meds have side effects. All meds have people who can't tolerate them. The push for buproprion reads more like an infomercial, a marketing campaign, than a real scientific endeavor.